Richard Bergström
Director/Board Member presso ISR IMMUNE SYSTEM REGULATION HOLDING AB (PUBL)
Profilo
Richard Bergström is the founder of PharmaCCX, Inc. He is currently a Director at ISR Immune System Regulation Holding AB and NorthX Biologics Matfors AB.
Previously, he served as the Director General of the European Federation of Pharmaceutical Industries & Assns from 2011 to 2017.
Posizioni attive di Richard Bergström
Società | Posizione | Inizio |
---|---|---|
ISR IMMUNE SYSTEM REGULATION HOLDING AB (PUBL) | Director/Board Member | 01/01/2022 |
PharmaCCX, Inc.
PharmaCCX, Inc. Internet Software/ServicesTechnology Services Pharmaccx, Inc. provides technology exchange platform. Its product enable pharmaceutical firm and payers to speed up their pricing negotiations, getting drugs to patients in need more quickly. The company was founded by Nathan Sigworth and Richard Bergstrom and is headquartered in Boston, MA. | Founder | - |
NorthX Biologics Matfors AB
NorthX Biologics Matfors AB BiotechnologyHealth Technology NorthX Biologics Matfors AB is a biologics company that specializes in high-quality protein production and DNA manufacturing. The company is based in Matfors, Sweden, and has subsidiaries in Sweden. The Swedish company offers comprehensive cell banking services, including master cell bank production, GMP cell banking, and cell bank characterization, ensuring quality and compliance for biological products. The company also provides premium plasmid DNA services, offering GMP, High Quality, and Research Grade plasmids for gene therapy, cell therapy, molecular biology research, and clinical applications. The company was founded in 1963, and Janet Hoogstraate has been the CEO of the company since 2023. | Director/Board Member | 14/06/2022 |
Precedenti posizioni note di Richard Bergström
Società | Posizione | Fine |
---|---|---|
European Federation of Pharmaceutical Industries & Assns
European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Chief Executive Officer | 30/04/2017 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 4 |
---|---|
European Federation of Pharmaceutical Industries & Assns
European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Commercial Services |
ISR Immune System Regulation Holding AB
ISR Immune System Regulation Holding AB Pharmaceuticals: MajorHealth Technology ISR Immune System Regulation Holding AB engages in pharmaceutical research for the treatment of viral diseases focusing on Human Immunodeficiency Virus (HIV). It is developing ISR048 for the novel treatment of HIV. The company was founded by Yen Lundgren and Ulf Ljungblad in September 17, 2015 and is headquartered in Solna, Sweden. | Health Technology |
PharmaCCX, Inc.
PharmaCCX, Inc. Internet Software/ServicesTechnology Services Pharmaccx, Inc. provides technology exchange platform. Its product enable pharmaceutical firm and payers to speed up their pricing negotiations, getting drugs to patients in need more quickly. The company was founded by Nathan Sigworth and Richard Bergstrom and is headquartered in Boston, MA. | Technology Services |
NorthX Biologics Matfors AB
NorthX Biologics Matfors AB BiotechnologyHealth Technology NorthX Biologics Matfors AB is a biologics company that specializes in high-quality protein production and DNA manufacturing. The company is based in Matfors, Sweden, and has subsidiaries in Sweden. The Swedish company offers comprehensive cell banking services, including master cell bank production, GMP cell banking, and cell bank characterization, ensuring quality and compliance for biological products. The company also provides premium plasmid DNA services, offering GMP, High Quality, and Research Grade plasmids for gene therapy, cell therapy, molecular biology research, and clinical applications. The company was founded in 1963, and Janet Hoogstraate has been the CEO of the company since 2023. | Health Technology |
- Borsa valori
- Insiders
- Richard Bergström